ambroxol has been researched along with Disease, Pulmonary in 32 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This paper was aimed at investigating the effects of bronchoalveolar lavage (BAL) with ambroxol hydrochloride (AH) on treating pulmonary infection and on serum proinflammatory cytokines and oxidative stress responses in patients with cerebral infarction (CI)." | 7.96 | Effects of Bronchoalveolar Lavage with Ambroxol Hydrochloride on Treating Pulmonary Infection in Patients with Cerebral Infarction and on Serum Proinflammatory Cytokines, MDA and SOD. ( Cheng, J; Meng, F; Sang, P; Wang, J, 2020) |
| "Although whole lung lavage is the first-line therapy for pulmonary alveolar proteinosis, oral ambroxol could be an alternative treatment option, even in patients with severe respiratory compromise." | 7.81 | Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report. ( Matsumoto, Y; Matsuoka, H; Oda, N; Okada, N; Suzuki, Y; Tamai, K; Yoshimatsu, H, 2015) |
| "This paper was aimed at investigating the effects of bronchoalveolar lavage (BAL) with ambroxol hydrochloride (AH) on treating pulmonary infection and on serum proinflammatory cytokines and oxidative stress responses in patients with cerebral infarction (CI)." | 3.96 | Effects of Bronchoalveolar Lavage with Ambroxol Hydrochloride on Treating Pulmonary Infection in Patients with Cerebral Infarction and on Serum Proinflammatory Cytokines, MDA and SOD. ( Cheng, J; Meng, F; Sang, P; Wang, J, 2020) |
| "Although whole lung lavage is the first-line therapy for pulmonary alveolar proteinosis, oral ambroxol could be an alternative treatment option, even in patients with severe respiratory compromise." | 3.81 | Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report. ( Matsumoto, Y; Matsuoka, H; Oda, N; Okada, N; Suzuki, Y; Tamai, K; Yoshimatsu, H, 2015) |
| " With regard to a possible therapeutic application in this context the effect of bromhexine and ambroxol on the activity of AM of of guinea-pigs and of patients with lung diseases was investigated." | 3.67 | [Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid]. ( Eckert, H; Grollmuss, H; Unger, U; Winsel, K, 1985) |
| "Ambroxol, a drug capable of elevating the phospholipid content in healthy rabbit lungs, was tested on two models of experimental lung injury, lung changes in sepsis induced by a peritonitis and in bromcarbamide intoxication." | 3.67 | Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders. ( Müller, B; von Wichert, P; Wilke, A, 1987) |
| "The clinical activity of trans-4-[(2-amino-3,5-dibromo-benzyl)-amino]-cyclohexanol-hydrochloride (ambroxol, NA 872) as well as its influence on lung function was examined in a total of 63 patients (34 suffering from silicosis, 28 from chronic obstructive bronchitis and 1 from cryptococcosis)." | 3.66 | [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)]. ( Curti, PC; Renovanz, HD, 1978) |
| "Fifty younger patients without known pulmonary disease were randomly assigned into 2 groups." | 2.73 | Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass. ( Cagli, K; Ergun, K; Gedik, S; Hizarci, M; Kocabeyoglu, SS; Korkmaz, K; Kunt, A; Lafci, G; Ulas, MM, 2008) |
| "Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions." | 2.49 | Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tam, J; Tullis, E, 2013) |
| "Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions." | 2.45 | Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tullis, E, 2009) |
| "This is most evident in pulmonary diseases characterized by low glutathione levels and high oxidant production by inflammatory cells (e." | 2.40 | Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. ( Gillissen, A; Nowak, D, 1998) |
| "Ambroxol has been established for decades in the treatment of acute and chronic respiratory diseases." | 1.46 | [More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases]. ( de Zeeuw, J; Plomer, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (62.50) | 18.7374 |
| 1990's | 3 (9.38) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 5 (15.63) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, F | 1 |
| Cheng, J | 1 |
| Sang, P | 1 |
| Wang, J | 1 |
| Plomer, M | 1 |
| de Zeeuw, J | 1 |
| Deretic, V | 1 |
| Timmins, GS | 1 |
| Dey, P | 1 |
| Banerjee, S | 1 |
| Mandal, S | 1 |
| Chattopadhyay, P | 1 |
| Tam, J | 1 |
| Nash, EF | 2 |
| Ratjen, F | 2 |
| Tullis, E | 2 |
| Stephenson, A | 2 |
| Oda, N | 1 |
| Tamai, K | 1 |
| Suzuki, Y | 1 |
| Yoshimatsu, H | 1 |
| Matsuoka, H | 1 |
| Matsumoto, Y | 1 |
| Okada, N | 1 |
| Ulas, MM | 1 |
| Hizarci, M | 1 |
| Kunt, A | 1 |
| Ergun, K | 1 |
| Kocabeyoglu, SS | 1 |
| Korkmaz, K | 1 |
| Lafci, G | 1 |
| Gedik, S | 1 |
| Cagli, K | 1 |
| PEPYS, J | 3 |
| WILLIAMS, JV | 1 |
| DONOGHUE, FE | 1 |
| SCHMIDT, HW | 1 |
| HOEER, PW | 2 |
| LONGBOTTOM, JL | 1 |
| JENKINS, PA | 1 |
| KUBASEK, M | 1 |
| HORBACH, L | 1 |
| SCHWEISFURTH, R | 1 |
| LONGBOTTON, JL | 1 |
| JENKINS, JA | 1 |
| REIMANN, HA | 1 |
| Akkoca Yildiz, O | 1 |
| Shimura, S | 1 |
| Okubo, T | 1 |
| Maeda, S | 1 |
| Aoki, T | 1 |
| Tomioka, M | 1 |
| Shindo, Y | 1 |
| Takishima, T | 1 |
| Umeya, K | 1 |
| Gillissen, A | 1 |
| Nowak, D | 1 |
| Curti, PC | 1 |
| Renovanz, HD | 1 |
| Marcatili, S | 1 |
| Guarino, C | 1 |
| Giannattasio, A | 1 |
| Marcatili, A | 1 |
| Festa, M | 1 |
| Cautiero, V | 1 |
| Marini, MG | 1 |
| Pierfederici, P | 1 |
| Dell'Orso, S | 1 |
| Cotrufo, M | 1 |
| Luisetti, M | 1 |
| Peona, V | 1 |
| Salmona, M | 1 |
| Pagnoni, AM | 1 |
| Villani, F | 1 |
| Knerich, R | 1 |
| Genghini, M | 1 |
| Abbà, L | 1 |
| Pozzi, E | 1 |
| Winsel, K | 1 |
| Grollmuss, H | 1 |
| Unger, U | 1 |
| Eckert, H | 1 |
| Solopov, VN | 1 |
| Kolganova, NA | 1 |
| Romanini, BM | 1 |
| Sandri, MG | 1 |
| Tosi, M | 1 |
| Mezzetti, M | 1 |
| Mazzetti, A | 1 |
| Wilke, A | 1 |
| Müller, B | 1 |
| von Wichert, P | 1 |
5 reviews available for ambroxol and Disease, Pulmonary
| Article | Year |
|---|---|
Enhancement of lung levels of antibiotics by ambroxol and bromhexine.
Topics: Ambroxol; Animals; Anti-Bacterial Agents; Bacterial Infections; Bromhexine; Drug Resistance, Bacteri | 2019 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi | 2013 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi | 2009 |
[Ambroxol].
Topics: Ambroxol; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchial Hyperreactivity; Cystic Fibrosis | 2006 |
Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Topics: Acetylcysteine; Ambroxol; Animals; Expectorants; Free Radical Scavengers; Humans; Lung; Lung Disease | 1998 |
4 trials available for ambroxol and Disease, Pulmonary
| Article | Year |
|---|---|
Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
Topics: Administration, Oral; Adult; Ambroxol; Bronchoalveolar Lavage Fluid; Cardiopulmonary Bypass; Coronar | 2008 |
Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo.
Topics: Adult; Aged; Ambroxol; Bromhexine; Chymotrypsin; Elasticity; Expectorants; Female; Humans; Lung Dise | 1983 |
Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation.
Topics: Adult; Ambroxol; Bronchoalveolar Lavage Fluid; Chromatography, Thin Layer; Extracorporeal Circulatio | 1990 |
Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
Topics: Adult; Aged; Ambroxol; Bromhexine; Bronchial Diseases; Clinical Trials as Topic; Double-Blind Method | 1986 |
23 other studies available for ambroxol and Disease, Pulmonary
| Article | Year |
|---|---|
Effects of Bronchoalveolar Lavage with Ambroxol Hydrochloride on Treating Pulmonary Infection in Patients with Cerebral Infarction and on Serum Proinflammatory Cytokines, MDA and SOD.
Topics: Ambroxol; Bronchoalveolar Lavage; Case-Control Studies; Cerebral Infarction; Computational Biology; | 2020 |
[More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases].
Topics: Ambroxol; Clinical Trials as Topic; Expectorants; Humans; Lung Diseases; Publications | 2017 |
Design and evaluation of anti-fibrosis drug engineered resealed erythrocytes for targeted delivery.
Topics: Albumins; Ambroxol; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Drug Carriers; Drug Liberation | 2019 |
FARMER'S lung.
Topics: Agriculture; Ambroxol; Farmer's Lung; Humans; Lung Diseases; Occupational Diseases | 1958 |
Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report.
Topics: Aged; Ambroxol; Autoimmune Diseases; Expectorants; Female; Granulocyte-Macrophage Colony-Stimulating | 2015 |
FARMER'S lung.
Topics: Agriculture; Ambroxol; Farmer's Lung; Humans; Lung Diseases | 1953 |
FARMER'S lung.
Topics: Agriculture; Ambroxol; Farmer's Lung; Lung Diseases; Medical Records; Mycoses; Occupational Diseases | 1958 |
HYPERSENSITIVITY REACTIONS IN MAN TO FUNGI, VEGETABLE DUSTS AND TUBERCULIN.
Topics: Ambroxol; Aspergillosis; Aspergillus; Dust; Farmer's Lung; Fungi; Humans; Hypersensitivity; Lung Dis | 1963 |
PULMONARY FUNCTION STUDIES IN PATIENTS WITH FARMER'S LUNG.
Topics: Agricultural Workers' Diseases; Ambroxol; Farmer's Lung; Humans; Lung Diseases; Respiratory Function | 1963 |
FARMER'S LUNG AND SILO-FILLER'S DISEASE.
Topics: Agricultural Workers' Diseases; Ambroxol; Dust; Farmer's Lung; Gas Poisoning; Humans; Hypersensitivi | 1964 |
[CONTRIBUTION TO THE PATHOGENESIS OF FARMER'S LUNG BASED ON ANIMAL EXPERIMENTS AND ON A CASE OF PRIMARY ACUTE PULMONARY ASPERGILLOSIS].
Topics: Adolescent; Agricultural Workers' Diseases; Ambroxol; Animal Experimentation; Animals; Aspergillosis | 1963 |
VEGETABLE DUST PNEUMOCONIOSES. IMMUNOLOGIC RESPONSES TO VEGETABLE DUSTS AND THEIR FLORA.
Topics: Agricultural Workers' Diseases; Ambroxol; Aspergillosis; C-Reactive Protein; Dust; Farmer's Lung; Fu | 1964 |
[FARMER'S LUNG--A MASS OUTBREAK].
Topics: Adolescent; Agricultural Workers' Diseases; Ambroxol; Czechoslovakia; Disease Outbreaks; Farmer's Lu | 1964 |
[THE DISEASE PICTURE OF THE FARMER'S LUNG AND ITS RELATION TO FUNGAL INFECTIONS].
Topics: Adolescent; Agricultural Workers' Diseases; Ambroxol; Aspergillosis; Farmer's Lung; Humans; Lung Dis | 1964 |
[PULMONARY ASPERGILLOSIS AND FARMER'S LUNG].
Topics: Allergy and Immunology; Ambroxol; Aspergillosis; Asthma; Eosinophilia; Farmer's Lung; Humans; Immuno | 1964 |
NONMICROBIC PNEUMONIAS AND PNEUMONOSES.
Topics: Air Pollution; Ambroxol; Asbestosis; Beryllium; Classification; Eosinophilic Granuloma; Farmer's Lun | 1964 |
[Ambroxol. Prophylaxis and therapy of pulmonary complications. Symposium on the occasion of the 12th International Sylt Week on Anesthesiology. 9 September 1998].
Topics: Ambroxol; Anesthesia; Dose-Response Relationship, Drug; Expectorants; Humans; Lung Diseases; Medicin | 1998 |
[Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
Topics: Ambroxol; Bromhexine; Bronchitis; Chronic Disease; Cryptococcosis; Humans; Lung Diseases; Lung Disea | 1978 |
Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
Topics: Ambroxol; Animals; Antineoplastic Agents; Bleomycin; Bromhexine; Busulfan; Cyclophosphamide; Humans; | 1986 |
[Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid].
Topics: Ambroxol; Animals; Arachidonic Acid; Arachidonic Acids; Bromhexine; Guinea Pigs; Luminescent Measure | 1985 |
[Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
Topics: Adhesiveness; Ambroxol; Bromhexine; Chronic Disease; Drug Evaluation; Humans; Lung Diseases; Mucocil | 1988 |
New aspects in the treatment of pulmonary and upper airways diseases. Proceedings of the satellite symposium to the 4th Congress of the European Society of Pneumology. Milano and Stresa, September 23-28, 1985.
Topics: Ambroxol; Animals; Bromhexine; Humans; Lung Diseases; Respiratory Tract Diseases | 1987 |
Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders.
Topics: Ambroxol; Animals; Bromhexine; Choline; Fatty Acids; Female; Lung; Lung Diseases; Male; Peritonitis; | 1987 |